News
Inventors at the NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) are seeking a licensee or collaborator for positive allosteric modulators (PAMs) of the A 3 adenosine receptor (A 3AR), a known therapeutic target. These heterocyclic chemical compounds bind to a lipid
Register for your spot at the National Cancer Institute (NCI) and Frederick National Lab (FNL) 2021 Technology Showcase. This event provides potential partners the opportunity to attend presentations on federal technologies ready for commercialization and/or collaboration, watch panel sessions
Two NIH Intramural Inventors have received an HHS departmental award. Steven Rosenberg, M.D., Ph.D. was awarded the Secretary’s Award for Distinguished Service. This is the highest honor given by HHS. Dr. Rosenberg is the Chief of Surgery Branch at the National Cancer Institute (NCI). The award he
Did you know that companies from other countries can collaborate with or license from the National Institutes of Health (NIH)? It can be daunting to find a technology that your company is interested in and know where to begin the collaborative process. If your company is interested in technology